|
ATCC
havsmcs ![]() Havsmcs, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/primary+aortic+smooth+muscle+cells/pmc12984406-77-0-1?v=ATCC Average 95 stars, based on 1 article reviews
havsmcs - by Bioz Stars,
2026-07
95/100 stars
|
Buy from Supplier |
|
Cell Applications Inc
rat primary aortic vsmcs ![]() Rat Primary Aortic Vsmcs, supplied by Cell Applications Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/primary+aortic+smooth+muscle+cells/pmc13142666-85-0-7?v=Cell+Applications+Inc Average 94 stars, based on 1 article reviews
rat primary aortic vsmcs - by Bioz Stars,
2026-07
94/100 stars
|
Buy from Supplier |
|
Cell Applications Inc
human vascular smooth muscle cells ![]() Human Vascular Smooth Muscle Cells, supplied by Cell Applications Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/primary+aortic+smooth+muscle+cells/bio_rxiv__64898__2026__05__09__724001-170-0-6?v=Cell+Applications+Inc Average 95 stars, based on 1 article reviews
human vascular smooth muscle cells - by Bioz Stars,
2026-07
95/100 stars
|
Buy from Supplier |
|
Boster Bio
anti αsmooth muscle actin primary antibody ![]() Anti αsmooth Muscle Actin Primary Antibody, supplied by Boster Bio, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/primary+aortic+smooth+muscle+cells/pm23321174-108-9-18?v=Boster+Bio Average 92 stars, based on 1 article reviews
anti αsmooth muscle actin primary antibody - by Bioz Stars,
2026-07
92/100 stars
|
Buy from Supplier |
|
Boster Bio
a sma ![]() A Sma, supplied by Boster Bio, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/primary+aortic+smooth+muscle+cells/pm36541354-58-36-42?v=Boster+Bio Average 94 stars, based on 1 article reviews
a sma - by Bioz Stars,
2026-07
94/100 stars
|
Buy from Supplier |
|
Cell Applications Inc
canine smooth muscle cells cnaosmc ![]() Canine Smooth Muscle Cells Cnaosmc, supplied by Cell Applications Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/primary+aortic+smooth+muscle+cells/pmc04391138-30-5-11?v=Cell+Applications+Inc Average 90 stars, based on 1 article reviews
canine smooth muscle cells cnaosmc - by Bioz Stars,
2026-07
90/100 stars
|
Buy from Supplier |
|
Cell Applications Inc
aortic smooth muscle cells ![]() Aortic Smooth Muscle Cells, supplied by Cell Applications Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/primary+aortic+smooth+muscle+cells/pmc01762698-81-14-18?v=Cell+Applications+Inc Average 90 stars, based on 1 article reviews
aortic smooth muscle cells - by Bioz Stars,
2026-07
90/100 stars
|
Buy from Supplier |
|
Boster Bio
mouse monoclonal smooth muscle actin sma antibody ![]() Mouse Monoclonal Smooth Muscle Actin Sma Antibody, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/primary+aortic+smooth+muscle+cells/pmc04707546-21-1-8?v=Boster+Bio Average 93 stars, based on 1 article reviews
mouse monoclonal smooth muscle actin sma antibody - by Bioz Stars,
2026-07
93/100 stars
|
Buy from Supplier |
|
Boster Bio
α smooth muscle actin ![]() α Smooth Muscle Actin, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/primary+aortic+smooth+muscle+cells/pm25572313-62-14-18?v=Boster+Bio Average 93 stars, based on 1 article reviews
α smooth muscle actin - by Bioz Stars,
2026-07
93/100 stars
|
Buy from Supplier |
|
Cell Applications Inc
bovine aortic smooth muscle cells ![]() Bovine Aortic Smooth Muscle Cells, supplied by Cell Applications Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/primary+aortic+smooth+muscle+cells/pm24156536__ja408634a_si_001-1-137-145?v=Cell+Applications+Inc Average 90 stars, based on 1 article reviews
bovine aortic smooth muscle cells - by Bioz Stars,
2026-07
90/100 stars
|
Buy from Supplier |
|
Innoprot Inc
aortic smooth muscle cells ![]() Aortic Smooth Muscle Cells, supplied by Innoprot Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/primary+aortic+smooth+muscle+cells/pmc12111853-104-2-9?v=Innoprot+Inc Average 94 stars, based on 1 article reviews
aortic smooth muscle cells - by Bioz Stars,
2026-07
94/100 stars
|
Buy from Supplier |
|
Lonza
primary human aortic smooth muscle cells aosmcs ![]() Primary Human Aortic Smooth Muscle Cells Aosmcs, supplied by Lonza, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/primary+aortic+smooth+muscle+cells/pmc04200242-156-0-10?v=Lonza Average 97 stars, based on 1 article reviews
primary human aortic smooth muscle cells aosmcs - by Bioz Stars,
2026-07
97/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Cells
Article Title: TMAO-Triggered Endothelial–Mesenchymal Transition and Microvesicle Release as Mediators of Vascular Smooth Muscle Cell Osteogenic Differentiation and Vascular Calcification
doi: 10.3390/cells15050466
Figure Lengend Snippet: Endothelial cell-derived exosomes influence vascular smooth muscle cell phenotype and calcification-related gene expression. HAVSMCs were incubated for 8 days with 10 µg/mL exosomes derived from endothelial cells (ECs) in ECM (control), TNFα, TGFβ, or varying concentrations of TMAO (1–100 μM). ( A – D ) qPCR analysis of osteogenic markers RUNX2 and OPN, confirming transcriptional reprogramming toward an osteoblast-like phenotype. ( E ) TNAP (Tissue Non-Specific Alkaline Phosphatase) involved in vascular calcification and osteogenic transformation of VSMCs. Data are presented as mean ± SD from four independent biological replicates. Statistical significance was determined by one-way ANOVA, followed by Tukey’s post hoc test. * p < 0.05, ** p < 0.01, *** p < 0.001 vs. SMCM control.
Article Snippet:
Techniques: Derivative Assay, Gene Expression, Incubation, Control, Transformation Assay
Journal: Cells
Article Title: TMAO-Triggered Endothelial–Mesenchymal Transition and Microvesicle Release as Mediators of Vascular Smooth Muscle Cell Osteogenic Differentiation and Vascular Calcification
doi: 10.3390/cells15050466
Figure Lengend Snippet: Differential effects of endothelial cell-derived exosomes on calcification of HAVSMCs, assessed by Alizarin Red staining. ( A – G ) Representative images of Alizarin Red staining in HAVSMCs after 8 days of culture with 10 µg/mL endothelial cell-derived exosomes (EC-EXOs) obtained from endothelial cell maintenance medium (ECM EC EXO), TNFα-stimulated EC exosomes (TNFα EC EXO), TGFβ-stimulated EC exosomes (TGFβ EC EXO), TMAO-treated EC exosomes (1 µM, 10 µM, and 50 µM TMAO EC EXO), and control smooth muscle cell medium (SMCM). ( H ) Quantification of Alizarin Red stain intensity was normalized to total protein concentration. Data are presented as mean ± SD from four independent biological replicates. Statistical significance was determined by one-way ANOVA, followed by Tukey’s post hoc test. * p < 0.05 vs. SMCM control.
Article Snippet:
Techniques: Derivative Assay, Staining, Control, Protein Concentration
Journal: Cells
Article Title: TMAO-Triggered Endothelial–Mesenchymal Transition and Microvesicle Release as Mediators of Vascular Smooth Muscle Cell Osteogenic Differentiation and Vascular Calcification
doi: 10.3390/cells15050466
Figure Lengend Snippet: β-catenin inhibition attenuates endothelial exosome-induced β-catenin activation in HAVSMCs. ( A , C ) Representative Western blot images showing non-phosphorylated (active) β-catenin protein expression in human aortic vascular smooth muscle cells (HAVSMCs) treated with endothelial cell-derived exosomes (EC-EXOs) obtained from TNFα-, TGFβ-, or TMAO-stimulated endothelial cells, in the presence or absence of the β-catenin transcriptional inhibitor ICG-001 for 8 days. β-actin was used as a loading control. ( B , D ) Quantitative densitometric analysis demonstrates a significant increase in β-catenin protein levels following EC-EXO treatment, which was markedly reduced upon β-catenin inhibition with ICG-001. Protein expression levels were normalized to β-actin and expressed as fold change relative to vehicle-treated controls. Data are presented as mean ± standard deviation (SD) from three independent biological replicates. Statistical significance was determined by one-way ANOVA followed by Tukey’s post hoc test to assess differences between EC-EXO treatment groups and the effect of β-catenin inhibition. * p < 0.05, ** p < 0.01, *** p < 0.001.
Article Snippet:
Techniques: Inhibition, Activation Assay, Western Blot, Expressing, Derivative Assay, Control, Standard Deviation
Journal: Cells
Article Title: TMAO-Triggered Endothelial–Mesenchymal Transition and Microvesicle Release as Mediators of Vascular Smooth Muscle Cell Osteogenic Differentiation and Vascular Calcification
doi: 10.3390/cells15050466
Figure Lengend Snippet: β-catenin inhibition suppresses endothelial exosome-induced osteogenic gene expression in HAVSMCs. ( A – E ) Quantitative real-time PCR analysis of osteogenic gene expression in HAVSMCs treated with endothelial cell-derived exosomes (EC-EXOs) from TNFα-, TGFβ-, or TMAO-stimulated endothelial cells, in the presence of the β-catenin inhibitor ICG-001. Relative mRNA expression levels of ( A ) SM22A, ( B ) αSMA, ( C ) RUNX2, ( D ) osteopontin (OPN), and ( E ) tissue-nonspecific alkaline phosphatase (TNAP) were normalized to housekeeping genes and expressed relative to vehicle-treated control cells (0.1% v / v DMSO). EC-EXO co-treatment with ICG-001 significantly attenuated the expression of RUNX2, OPN, and TNAP, indicating that β-catenin signaling is required for endothelial exosome-induced osteogenic reprogramming of HAVSMCs. Data are presented as mean ± SD from three independent biological replicates. Statistical significance was assessed using one-way ANOVA, followed by post-hoc analysis. * p < 0.05, ** p < 0.01, *** p < 0.001, vs. CTL vehicle.
Article Snippet:
Techniques: Inhibition, Gene Expression, Real-time Polymerase Chain Reaction, Derivative Assay, Expressing, Control
Journal: Cells
Article Title: TMAO-Triggered Endothelial–Mesenchymal Transition and Microvesicle Release as Mediators of Vascular Smooth Muscle Cell Osteogenic Differentiation and Vascular Calcification
doi: 10.3390/cells15050466
Figure Lengend Snippet: Uptake kinetics of MemBright-labeled endothelial cell-derived exosomes by HAVSMC. Representative confocal microscopy images showing the time-dependent uptake of MemBright-labeled endothelial cell-derived exosomes by human aortic vascular smooth muscle cells (HAVSMCs). ( A ) HAVSMCs treated with control endothelial cell-derived exosomes (CTL EC EXO). ( B ) HAVSMCs treated with exosomes derived from endothelial cells exposed to 50 µM TMAO (TMAO EC EXO). Exosomes were labeled with MemBright (green), and cell nuclei were counterstained with Hoechst (blue). Images were acquired immediately after exosome addition (T = 0 h) and after 1, 3, and 4 h of incubation. Merged images illustrate progressive internalization and intracellular accumulation of exosomes over time, with 20× objective. All images were captured using a Leica confocal laser scanning microscope under identical acquisition settings. Scale bar: 194 µm.
Article Snippet:
Techniques: Labeling, Derivative Assay, Confocal Microscopy, Control, Incubation, Laser-Scanning Microscopy
Journal: Cells
Article Title: TMAO-Triggered Endothelial–Mesenchymal Transition and Microvesicle Release as Mediators of Vascular Smooth Muscle Cell Osteogenic Differentiation and Vascular Calcification
doi: 10.3390/cells15050466
Figure Lengend Snippet: miR-222-3p overexpression promotes osteogenic signaling in HAVSMCs through activation of β-catenin pathway. ( A ) Quantitative PCR analysis confirming successful transfection of HAVSMCs with miR-222-3p mimic compared with the results for scrambled mimic control. Relative miR-222-3p expression levels were normalized to miR5S and expressed as fold change. ( B – F ) Quantitative PCR analysis of gene expression levels of RUNX2, OPN and TNAP in HAVSMCs after miR-222-3p mimic transfection for 48 h. ( G ) Representative Western blot images showing β-catenin protein expression in HAVSMCs following transfection with scrambled mimic or miR-222-3p mimic. ( H ) Quantitative densitometric analysis of protein expression levels of β-catenin protein expression levels were normalized to housekeeping protein and expressed relative to scrambled control. Data are presented as mean ± SD from independent biological replicates. Statistical significance was determined using unpaired two-tailed Student’s t -test. * p < 0.05, ** p < 0.01, *** p < 0.001 vs. scrambled mimic control.
Article Snippet:
Techniques: Over Expression, Activation Assay, Real-time Polymerase Chain Reaction, Transfection, Control, Expressing, Gene Expression, Western Blot, Two Tailed Test
Journal: The Journal of international medical research
Article Title: Physical properties of poly(N-isopropylacrylamide) hydrogel promote its effects on cardiac protection after myocardial infarction.
doi: 10.1177/030006051204000615
Figure Lengend Snippet: FIGURE 6: Neovasculature formation in sham-operated and infarct areas of myocardium 90 days after induction of myocardial infarction (MI) in rats, as identified by immunohistochemical staining for α-smooth muscle actin. (A) Sham-operated group; (B) phosphate-buffered saline (PBS)-treated MI group; (C) Gel A-treated MI group; (D) Gel B-treated MI group (scale bars, 100 µm). Immunohistochemical staining was used to quantify (E) blood vessel density per high-power field (HPF) in each group. Black arrows show neovasculature formed in sham-operated or infarcted myocardium. aP < 0.05 compared with sham-operated group; bP < 0.05 compared with MI + PBS group; one-way analysis of variance and unpaired Student’s t-test
Article Snippet: The slides were incubated overnight at 4 °C with
Techniques: Immunohistochemical staining, Staining, Saline